EX-1 2 ex_1.htm EXHIBIT 1

 

 

EXHIBIT 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of this Schedule 13G/A (including amendments thereto) with respect to the Common Stock of Cantaloupe, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.  In evidence thereof, the undersigned, hereby execute this Agreement this 25th day of January, 2023.

 

  January 25, 2023  
  Date  
     
  ARDSLEY ADVISORY PARTNERS LP  
 

By: Ardsley Advisory Partners GP LLC, its general partner

  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/ Member  
  Name/Title  
     
  January 25, 2023  
  Date  
     
  ARDSLEY ADVISORY PARTNERS GP LLC  
     
  /s/ Steve Napoli  
  Signature  
     
 

Steve Napoli/ Member

  
 

Name/Title

  
     
  January 25, 2023  
  Date  
     
  ARDSLEY PARTNERS I GP LLC  
     
  /s/ Steve Napoli  
  Signature  
     
  Steve Napoli/ Member  
  Name/Title  
 
 

 

  January 25, 2023  
  Date  
     
  PHILIP J. HEMPLEMAN  
     
  /s/ Steve Napoli*  
  Signature  
     
  Steve Napoli/Attorney-in Fact for Philip J. Hempleman  
 

Name/Title

  
     
  January 25, 2023  
  Date  
     
  ARDSLEY PARTNERS ADVANCED HEALTHCARE FUND, L.P.
 

By: Ardsley Partners I GP LLC, its general partner

  
     
  /s/ Steve Napoli  
  Signature  
     
 

Steve Napoli/ Member

  
 

Name/Title

  

 

* Executed by Steve Napoli as Attorney-in-Fact for Philip J. Hempleman. The Power of Attorney for Mr. Hempleman is attached as Exhibit 2 to the Statement on Schedule 13G with respect to the Common Stock of Vaxgen, Inc., filed on February 15, 2006, and is incorporated herein by reference.